Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C7H4Cl2O3 |
| Molecular Weight | 207.011 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)C1=CC(Cl)=CC(Cl)=C1O
InChI
InChIKey=CNJGWCQEGROXEE-UHFFFAOYSA-N
InChI=1S/C7H4Cl2O3/c8-3-1-4(7(11)12)6(10)5(9)2-3/h1-2,10H,(H,11,12)
| Molecular Formula | C7H4Cl2O3 |
| Molecular Weight | 207.011 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Structure-based optimization and biological evaluation of human 20α-hydroxysteroid dehydrogenase (AKR1C1) salicylic acid-based inhibitors. | 2010-11 |
|
| Correlation of binding constants and molecular modelling of inhibitors in the active sites of aldose reductase and aldehyde reductase. | 2009-02-01 |
|
| Structure of aldehyde reductase in ternary complex with coenzyme and the potent 20alpha-hydroxysteroid dehydrogenase inhibitor 3,5-dichlorosalicylic acid: implications for inhibitor binding and selectivity. | 2008-11-01 |
|
| Selectivity determinants of inhibitor binding to human 20alpha-hydroxysteroid dehydrogenase: crystal structure of the enzyme in ternary complex with coenzyme and the potent inhibitor 3,5-dichlorosalicylic acid. | 2008-08-14 |
|
| Identification of a cytochrome P450 cDNA (CYP98A5) from Phaseolus vulgaris, inducible by 3,5-dichlorosalicylic acid and 2,6-dichloro isonicotinic acid. | 2007-04 |
|
| Salicylic acid, an ambimobile molecule exhibiting a high ability to accumulate in the phloem. | 2006-08 |
|
| Salicylate activity. 3. Structure relationship to systemic acquired resistance. | 2005-12-14 |
|
| Guest-controlling effects on ER behaviors of beta-cyclodextrin polymer. | 2005-09-01 |
|
| Biochemical and molecular characterization of a ring fission dioxygenase with the ability to oxidize (substituted) salicylate(s) from Pseudaminobacter salicylatoxidans. | 2004-09-03 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:23:18 GMT 2025
by
admin
on
Mon Mar 31 22:23:18 GMT 2025
|
| Record UNII |
O6PXR32G3V
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
206-281-8
Created by
admin on Mon Mar 31 22:23:19 GMT 2025 , Edited by admin on Mon Mar 31 22:23:19 GMT 2025
|
PRIMARY | |||
|
5562
Created by
admin on Mon Mar 31 22:23:19 GMT 2025 , Edited by admin on Mon Mar 31 22:23:19 GMT 2025
|
PRIMARY | |||
|
O6PXR32G3V
Created by
admin on Mon Mar 31 22:23:19 GMT 2025 , Edited by admin on Mon Mar 31 22:23:19 GMT 2025
|
PRIMARY | |||
|
DTXSID3044914
Created by
admin on Mon Mar 31 22:23:19 GMT 2025 , Edited by admin on Mon Mar 31 22:23:19 GMT 2025
|
PRIMARY | |||
|
9445
Created by
admin on Mon Mar 31 22:23:19 GMT 2025 , Edited by admin on Mon Mar 31 22:23:19 GMT 2025
|
PRIMARY | |||
|
320-72-9
Created by
admin on Mon Mar 31 22:23:19 GMT 2025 , Edited by admin on Mon Mar 31 22:23:19 GMT 2025
|
PRIMARY | |||
|
30109
Created by
admin on Mon Mar 31 22:23:19 GMT 2025 , Edited by admin on Mon Mar 31 22:23:19 GMT 2025
|
PRIMARY |